NAGA antibody (N-Term)
Quick Overview for NAGA antibody (N-Term) (ABIN2774368)
Target
See all NAGA AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Sequence
- GYTYLNIDDC WIGGRDASGR LMPDPKRFPH GIPFLADYVH SLGLKLGIYA
-
Predicted Reactivity
- Dog: 79%, Horse: 86%, Human: 100%, Mouse: 93%, Pig: 86%, Rabbit: 79%, Rat: 86%
-
Characteristics
- This is a rabbit polyclonal antibody against NAGA. It was validated on Western Blot.
-
Purification
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the N-terminal region of NAGA
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator.
-
Comment
-
Antigen size: 411 AA
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- NAGA (N-Acetylgalactosaminidase, alpha (NAGA))
-
Alternative Name
- NAGA
-
Background
-
NAGA encodes the lysosomal enzyme alpha-N-acetylgalactosaminidase, which cleaves alpha-N-acetylgalactosaminyl moieties from glycoconjugates. Mutations in NAGA have been identified as the cause of Schindler disease types I and II (type II also known as Kanzaki disease).
Alias Symbols: D22S674, GALB
Protein Interaction Partner: APP, FBXO6, UBC, GNGT1,
Protein Size: 411 -
Molecular Weight
- 45 kDa
-
Gene ID
- 4668
-
NCBI Accession
- NM_000262, NP_000253
-
UniProt
- P17050
Target
-